$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates
10:35pm, Monday, 03'rd Aug 2020
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 21.05% and 23.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California, Inc. Announces Second Quarter 2020 Financial Results
08:02pm, Monday, 03'rd Aug 2020
MENLO PARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020. Total revenu
Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering
Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and As
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
03:08pm, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.COVID-19 news flow continued to pour in, with big pharma tie-ups f
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Analysts Estimate Pacific Biosciences of California (PACB) to Report a Decline in Earnings: What to Look Out for
04:31pm, Monday, 27'th Jul 2020
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pacific Biosciences of California (PACB) Scheduled to Post Earnings on Monday
06:42am, Monday, 27'th Jul 2020
Pacific Biosciences of California (NASDAQ:PACB) is scheduled to be posting its quarterly earnings results after the market closes on Monday, August 3rd. Analysts expect Pacific Biosciences of Californ
Coronavirus: 4 in Bukit Panjang transport hub cluster are drivers
09:00pm, Sunday, 26'th Jul 2020
Four coronavirus patients linked to a cluster at Bukit Panjang Integrated Transport Hub are all bus drivers, said transport operator SMRT yesterday.. Read more at straitstimes.com.
Coronavirus: Four infected people from Bukit Panjang Integrated Transport Hub cluster are all bus drivers
10:24am, Sunday, 26'th Jul 2020
SINGAPORE - Four coronavirus patients linked to a cluster at Bukit Panjang Integrated Transport Hub are all bus drivers, said transport operator SMRT on Sunday (July 26).. Read more at straitstimes.co
Pacific Biosciences of California, Inc. Second Quarter 2020 Financial Results Call
04:07pm, Friday, 24'th Jul 2020
MENLO PARK, Calif., July 24, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Result
SMRT disposes of two subsidiaries for RM5.1m, reports wider 1Q net loss
10:30am, Tuesday, 14'th Jul 2020
KUALA LUMPUR (July 14) : SMRT Holdings Bhd, whose net loss widened in the first quarter ended March 31, 2020 (1QFY20), is selling off two subsidiaries— Talentoz Sdn Bhd and Forzia Tech Pte Ltd— fo
Geode Capital Management LLC Boosts Stake in Pacific Biosciences of California (NASDAQ:PACB)
05:03am, Monday, 06'th Jul 2020
Geode Capital Management LLC grew its position in shares of Pacific Biosciences of California (NASDAQ:PACB) by 6.2% during the first quarter, according to its most recent filing with the SEC. The firm
Victory Capital Management Inc. Trims Position in Pacific Biosciences of California (NASDAQ:PACB)
04:14am, Sunday, 05'th Jul 2020
Victory Capital Management Inc. trimmed its holdings in Pacific Biosciences of California (NASDAQ:PACB) by 22.4% in the first quarter, according to its most recent disclosure with the SEC. The fund ow
Brokerages Expect Pacific Biosciences of California (NASDAQ:PACB) Will Post Earnings of -$0.19 Per Share
06:20am, Thursday, 02'nd Jul 2020
Brokerages forecast that Pacific Biosciences of California (NASDAQ:PACB) will post earnings per share of ($0.19) for the current quarter, according to Zacks. Three analysts have issued estimates for P
Sign In
Buy PACB